We are live on ! Find out more
BCPC

Balchem Corp

195 hedge funds and large institutions have $2.3B invested in Balchem Corp in 2017 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 81 increasing their positions, 53 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

53% more repeat investments, than reductions

Existing positions increased: 81 | Existing positions reduced: 53

8% more capital invested

Capital invested by funds: $2.13B → $2.3B (+$169M)

2.91% more ownership

Funds ownership: 85.97%88.88% (+2.9%)

6% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 18

3% less funds holding

Funds holding: 202195 (-7)

Holders
195
Holders Change
-7
Holders Change %
-3.47%
% of All Funds
4.85%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.05%
New
17
Increased
81
Reduced
53
Closed
18
Calls
$285K
Puts
Net Calls
+$285K
Net Calls Change
-$1.12M

BCPC Hedge Fund Activity: Q3 2017 in Review

195 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Balchem Corp (BCPC) for Q3 2017, worth a combined $2.3B — up 8% from $2.13B a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of BCPC and 17 opened new positions — a net loss of 1 holder — while 53 trimmed existing stakes and 81 added.

The largest buyer was Brown Capital Management, adding an estimated $15.9M. The largest seller was Rice Hall James & Associates, exiting entirely with an estimated $10.2M sold.

  • 195 institutional investors held Balchem Corp (BCPC) as of Q3 2017, down from 202 in Q2 2017.
  • Funds reported $2.3B of Balchem Corp stock for Q3 2017, up 8% quarter-over-quarter.
  • 17 funds opened new Balchem Corp positions in Q3 2017 and 18 closed out, a net change of -1 holder.
  • The largest Balchem Corp buyer in Q3 2017 was Brown Capital Management, an estimated $15.9M added.
  • The largest Balchem Corp seller in Q3 2017 was Rice Hall James & Associates, an estimated $10.2M sold.

Based on aggregated 13F filings for Q3 2017.